Evocutis PLC - Result of AGM

Evocutis plc

("the Company")

Result of AGM

Evocutis plc (AIM:EVO), the company focussed on advanced laboratory and clinical evaluations of skincare products for the health and cosmetic markets, announces that all resolutions proposed at the Company's Annual General Meeting held today were duly passed.

- Ends -

For further information please contact Evocutis plc:

Media (Frankfurt: 725292 - news) enquiries:

Notes to editors

About Evocutis plc

With a rich portfolio of new product opportunities, Evocutis offers antimicrobial and dermatological expertise to the cosmetic, consumer healthcare and pharmaceutical industries. Being uniquely able to combine research for laboratory testing, advanced skin models and clinical testing, Evocutis offers a complete service for the development of skin care products and ingredients. Through research and testing we enable our clients to advance the discovery of skin care products that actually work.

Offering high quality contract research services, Evocutis specialises in Human Skin Microbiology, tissue culture systems and Human Volunteer and Clinical Dermatology Research. Unique (Taiwan OTC: 3441.TWO - news) characteristics of its colonised full thickness model of human skin (LabSkin™) allow rapid, cost effective screening of, for example, anti-ageing, anti-inflammatory and antimicrobial ingredients and products for use on skin. Additionally, the clinical, human volunteer testing facility that is housed on-site provides rapid, bespoke evaluation of dermatological products.

When it comes to advanced laboratory and clinical evaluations of skincare products for the health and cosmetic markets, the Evocutis focus is simple: intelligent and specialised R∓D input.

For further information, please see www.evocutis.com